Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CONRAD is a non-profit organization dedicated to improving global reproductive health by developing new, safe, and affordable contraceptive methods and HIV prevention technologies. Established in 1986 through a cooperative agreement between Eastern Virginia Medical School (EVMS) and USAID, the organization operates as a Product Development Partnership (PDP). CONRAD focuses on the development of multipurpose prevention technologies (MPTs) that simultaneously prevent unintended pregnancy and the transmission of sexually transmitted infections, including HIV. Their research portfolio includes innovative delivery systems such as long-acting intravaginal rings, gels, and injectables, with a specific focus on meeting the needs of women in low-resource settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CONRAD Clinical Research Center.